Cargando…

Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction

BACKGROUND: Insulin resistance is known to be a common feature of type 2 diabetes mellitus and is regarded as an important mechanism in the pathogenesis of this disease. The key pathogenetic mechanisms of insulin resistance progression are free fatty acids metabolism impairment and enhanced activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Gruzdeva, Olga, Uchasova, Evgenya, Dyleva, Yulia, Belik, Ekaterina, Shurygina, Ekaterina, Barbarash, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746783/
https://www.ncbi.nlm.nih.gov/pubmed/23976861
http://dx.doi.org/10.2147/DMSO.S46627
_version_ 1782280842269163520
author Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Shurygina, Ekaterina
Barbarash, Olga
author_facet Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Shurygina, Ekaterina
Barbarash, Olga
author_sort Gruzdeva, Olga
collection PubMed
description BACKGROUND: Insulin resistance is known to be a common feature of type 2 diabetes mellitus and is regarded as an important mechanism in the pathogenesis of this disease. The key pathogenetic mechanisms of insulin resistance progression are free fatty acids metabolism impairment and enhanced activity of plasminogen activator inhibitor 1. Both free fatty acids and plasminogen activator inhibitor 1 are recognized as risk factors for coronary heart disease. METHODS: The patients were divided into two groups: group 1 included 65 non-diabetic myocardial infarction patients and group 2 enrolled 60 diabetic myocardial infarction patients. The control group consisted of 30 sex- and age-matched volunteers. The concentration of serum free fatty acids, glucose, C-peptide, and insulin were measured on the 1st and 12th days of the study. All the patients had their postprandial glycemia, insulin, and C-peptide concentrations measured 2 hours after a standard carbohydrate breakfast containing 360 kcal (protein 20 g, carbohydrate 57 g, and fat 9 g). RESULTS: Free fatty acids levels in group 1 and in group 2 exceeded the control group values by 7-fold and 11-fold, respectively. Plasminogen activator inhibitor 1 concentration was 2.5-fold higher in group 1 and 4.6-fold higher in group 2 compared to the control group on the 1st day from the myocardial infarction onset. In addition, plasminogen activator inhibitor 1 concentration was significantly reduced in both groups on the 12th day from the myocardial infarction onset; however, it did not achieve the control group values. CONCLUSION: Increased postprandial glucose level, insulinemia, and elevated levels of free fatty acids and plasminogen activator inhibitor are associated with myocardial infarction-associated progression of insulin resistance. However, insulin resistance metabolic markers are of great predictive capacity in the assessment of risk of acute coronary events.
format Online
Article
Text
id pubmed-3746783
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37467832013-08-23 Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Shurygina, Ekaterina Barbarash, Olga Diabetes Metab Syndr Obes Original Research BACKGROUND: Insulin resistance is known to be a common feature of type 2 diabetes mellitus and is regarded as an important mechanism in the pathogenesis of this disease. The key pathogenetic mechanisms of insulin resistance progression are free fatty acids metabolism impairment and enhanced activity of plasminogen activator inhibitor 1. Both free fatty acids and plasminogen activator inhibitor 1 are recognized as risk factors for coronary heart disease. METHODS: The patients were divided into two groups: group 1 included 65 non-diabetic myocardial infarction patients and group 2 enrolled 60 diabetic myocardial infarction patients. The control group consisted of 30 sex- and age-matched volunteers. The concentration of serum free fatty acids, glucose, C-peptide, and insulin were measured on the 1st and 12th days of the study. All the patients had their postprandial glycemia, insulin, and C-peptide concentrations measured 2 hours after a standard carbohydrate breakfast containing 360 kcal (protein 20 g, carbohydrate 57 g, and fat 9 g). RESULTS: Free fatty acids levels in group 1 and in group 2 exceeded the control group values by 7-fold and 11-fold, respectively. Plasminogen activator inhibitor 1 concentration was 2.5-fold higher in group 1 and 4.6-fold higher in group 2 compared to the control group on the 1st day from the myocardial infarction onset. In addition, plasminogen activator inhibitor 1 concentration was significantly reduced in both groups on the 12th day from the myocardial infarction onset; however, it did not achieve the control group values. CONCLUSION: Increased postprandial glucose level, insulinemia, and elevated levels of free fatty acids and plasminogen activator inhibitor are associated with myocardial infarction-associated progression of insulin resistance. However, insulin resistance metabolic markers are of great predictive capacity in the assessment of risk of acute coronary events. Dove Medical Press 2013-08-13 /pmc/articles/PMC3746783/ /pubmed/23976861 http://dx.doi.org/10.2147/DMSO.S46627 Text en © 2013 Gruzdeva et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Shurygina, Ekaterina
Barbarash, Olga
Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
title Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
title_full Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
title_fullStr Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
title_full_unstemmed Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
title_short Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
title_sort plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746783/
https://www.ncbi.nlm.nih.gov/pubmed/23976861
http://dx.doi.org/10.2147/DMSO.S46627
work_keys_str_mv AT gruzdevaolga plasminogenactivatorinhibitor1freefattyacidsandinsulinresistanceinpatientswithmyocardialinfarction
AT uchasovaevgenya plasminogenactivatorinhibitor1freefattyacidsandinsulinresistanceinpatientswithmyocardialinfarction
AT dylevayulia plasminogenactivatorinhibitor1freefattyacidsandinsulinresistanceinpatientswithmyocardialinfarction
AT belikekaterina plasminogenactivatorinhibitor1freefattyacidsandinsulinresistanceinpatientswithmyocardialinfarction
AT shuryginaekaterina plasminogenactivatorinhibitor1freefattyacidsandinsulinresistanceinpatientswithmyocardialinfarction
AT barbarasholga plasminogenactivatorinhibitor1freefattyacidsandinsulinresistanceinpatientswithmyocardialinfarction